Cardiac transthyretin amyloidosis in aortic valve replacement: RAISE score performance in the postoperative setting
After AVR, the complex RAISE Score showed lower sensitivity than originally reported, while simpler parameters demonstrated comparable predictive value for ATTR-CM screening. Advanced age, CTS history and elevated NT-proBNP levels seem most valuable for identifying candidates for bone scintigraphy.
Authors
- Stephan Nienaber (ORCID: https://orcid.org/0000-0001-5779-7549)
- Roman Pfister (ORCID: https://orcid.org/0000-0002-4358-5008)
- Μαρία Παπαθανασίου (ORCID: https://orcid.org/0000-0002-2801-7942)
- Stephan Baldus
- Matthieu Schäfer (ORCID: https://orcid.org/0000-0003-1875-1163)
- Sascha Macherey‐Meyer (ORCID: https://orcid.org/0000-0002-7080-6611)
- Jasper F. Nies (ORCID: https://orcid.org/0000-0003-3751-4008)
- Richard J. Nies (ORCID: https://orcid.org/0000-0002-1336-6031)
- Fabian Voß (ORCID: https://orcid.org/0000-0002-1098-9284)
- Clemens Metze (ORCID: https://orcid.org/0000-0001-8980-4598)
- Katharina Seuthe
- Matti Adam (ORCID: https://orcid.org/0000-0002-6990-8135)
- Merve Kural
- Can Öztürk (ORCID: https://orcid.org/0000-0002-9204-3838)
- Svenja Ney
- Amin Polzin
- Jan Grobecker
- Friedrich Gruenagel
Institutions
- Goethe University Frankfurt (DE)
- University Hospital Bonn (DE)
- Düsseldorf University Hospital (DE)
- University Hospital Frankfurt (DE)
- University Hospital Cologne (DE)
- Heinrich Heine University Düsseldorf (DE)
Publication Details
- Journal
- Clinical Research in Cardiology
- Published
- 2025-11-04
- DOI
- https://doi.org/10.1007/s00392-025-02766-6
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer